Prevalence and molecular characterization of drug-resistant Mycobacterium tuberculosis in Heyuan City in China

PurposeTuberculosis (TB) represents a significant global public health challenge, with China identified as a high-burden country. Data on the prevalence of drug resistance is crucial for informing the selection of appropriate pharmacological interventions for the treatment of drug-resistant tubercul...

Full description

Saved in:
Bibliographic Details
Main Authors: Dan Qiu, JianHong Ma, ZhiFang Liu, XiangXing Zeng
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2025.1586938/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850160604417884160
author Dan Qiu
Dan Qiu
JianHong Ma
ZhiFang Liu
XiangXing Zeng
author_facet Dan Qiu
Dan Qiu
JianHong Ma
ZhiFang Liu
XiangXing Zeng
author_sort Dan Qiu
collection DOAJ
description PurposeTuberculosis (TB) represents a significant global public health challenge, with China identified as a high-burden country. Data on the prevalence of drug resistance is crucial for informing the selection of appropriate pharmacological interventions for the treatment of drug-resistant tuberculosis (DR-TB).To evaluate the prevalence and drug resistance patterns among patients with DR-TB in Heyuan City, China.MethodsAll 291 patients registered between April 2021 and March 2023 were tested for drug resistance, and information about their medical history and demographics was collected directly from the hospital’s computer database. Eight genes were analyzed for mutations associated with resistance to five antituberculosis drugs: the katG, ahpC, and inhA promoters for isoniazid (INH); rpoB for rifampicin (RIF); embB for ethambutol (EMB); gyrA for fluoroquinolones (FQs); and rrs and rpsL for streptomycin (STR). All strains were genotyped using fluorescence melting curve analysis.ResultsIn Heyuan, 24.4% (71/291) of patients with treatment-resistant TB were resistant to at least one drug. Following are the rates of general resistance to each drug: RIF (28/272, 10.29%), INH (38/274, 13.87%), FQs (10/259, 3.86%), EMB (20/248, 8.06%), and STR (15/150, 10.00%). Age or gender had no statistically significant impact on the likelihood of developing drug resistance. Nevertheless, a statistically significant difference was observed between the three strategies of drug resistance testing, AFB testing, and MTB antibody testing. There were 48 cases of single-drug resistance and 23 cases of multiple-drug resistance among the 71 drug-resistant patients. Eight genes had 127 altered nucleotide sequences, with KatG315 (20.47%) having the most significant incidence of mutations. The top three mutated genes were rpoB (32.28%), katG (23.62%), and embB (15.75%).ConclusionThese findings may be helpful in Heyuan City for the quick molecular identification of DR-TB isolates in clinical samples.
format Article
id doaj-art-ae131dda5e7d47a3998e2e3efb837e94
institution OA Journals
issn 2235-2988
language English
publishDate 2025-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj-art-ae131dda5e7d47a3998e2e3efb837e942025-08-20T02:23:06ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882025-06-011510.3389/fcimb.2025.15869381586938Prevalence and molecular characterization of drug-resistant Mycobacterium tuberculosis in Heyuan City in ChinaDan Qiu0Dan Qiu1JianHong Ma2ZhiFang Liu3XiangXing Zeng4Medical Laboratory, Heyuan Key Laboratory of Molecular Diagnosis and Disease Prevention and Treatment, Doctors Station of Guangdong Province, Heyuan People’s Hospital, Heyuan, Guangdong, ChinaDepartment of Traditional Chinese Medicine, Heyuan People’s Hospital, Heyuan, Guangdong, ChinaDepartment of Clinical Laboratory, Heyuan People’s Hospital, Heyuan, Guangdong, ChinaDepartment of Integrated Enforcement, Heyuan Health Supervision Institute, Heyuan, Guangdong, ChinaMedical Laboratory, Heyuan Key Laboratory of Molecular Diagnosis and Disease Prevention and Treatment, Doctors Station of Guangdong Province, Heyuan People’s Hospital, Heyuan, Guangdong, ChinaPurposeTuberculosis (TB) represents a significant global public health challenge, with China identified as a high-burden country. Data on the prevalence of drug resistance is crucial for informing the selection of appropriate pharmacological interventions for the treatment of drug-resistant tuberculosis (DR-TB).To evaluate the prevalence and drug resistance patterns among patients with DR-TB in Heyuan City, China.MethodsAll 291 patients registered between April 2021 and March 2023 were tested for drug resistance, and information about their medical history and demographics was collected directly from the hospital’s computer database. Eight genes were analyzed for mutations associated with resistance to five antituberculosis drugs: the katG, ahpC, and inhA promoters for isoniazid (INH); rpoB for rifampicin (RIF); embB for ethambutol (EMB); gyrA for fluoroquinolones (FQs); and rrs and rpsL for streptomycin (STR). All strains were genotyped using fluorescence melting curve analysis.ResultsIn Heyuan, 24.4% (71/291) of patients with treatment-resistant TB were resistant to at least one drug. Following are the rates of general resistance to each drug: RIF (28/272, 10.29%), INH (38/274, 13.87%), FQs (10/259, 3.86%), EMB (20/248, 8.06%), and STR (15/150, 10.00%). Age or gender had no statistically significant impact on the likelihood of developing drug resistance. Nevertheless, a statistically significant difference was observed between the three strategies of drug resistance testing, AFB testing, and MTB antibody testing. There were 48 cases of single-drug resistance and 23 cases of multiple-drug resistance among the 71 drug-resistant patients. Eight genes had 127 altered nucleotide sequences, with KatG315 (20.47%) having the most significant incidence of mutations. The top three mutated genes were rpoB (32.28%), katG (23.62%), and embB (15.75%).ConclusionThese findings may be helpful in Heyuan City for the quick molecular identification of DR-TB isolates in clinical samples.https://www.frontiersin.org/articles/10.3389/fcimb.2025.1586938/fulldrug resistancegene mutationMDR-TBfluorescence melting curve analysisHeyuan
spellingShingle Dan Qiu
Dan Qiu
JianHong Ma
ZhiFang Liu
XiangXing Zeng
Prevalence and molecular characterization of drug-resistant Mycobacterium tuberculosis in Heyuan City in China
Frontiers in Cellular and Infection Microbiology
drug resistance
gene mutation
MDR-TB
fluorescence melting curve analysis
Heyuan
title Prevalence and molecular characterization of drug-resistant Mycobacterium tuberculosis in Heyuan City in China
title_full Prevalence and molecular characterization of drug-resistant Mycobacterium tuberculosis in Heyuan City in China
title_fullStr Prevalence and molecular characterization of drug-resistant Mycobacterium tuberculosis in Heyuan City in China
title_full_unstemmed Prevalence and molecular characterization of drug-resistant Mycobacterium tuberculosis in Heyuan City in China
title_short Prevalence and molecular characterization of drug-resistant Mycobacterium tuberculosis in Heyuan City in China
title_sort prevalence and molecular characterization of drug resistant mycobacterium tuberculosis in heyuan city in china
topic drug resistance
gene mutation
MDR-TB
fluorescence melting curve analysis
Heyuan
url https://www.frontiersin.org/articles/10.3389/fcimb.2025.1586938/full
work_keys_str_mv AT danqiu prevalenceandmolecularcharacterizationofdrugresistantmycobacteriumtuberculosisinheyuancityinchina
AT danqiu prevalenceandmolecularcharacterizationofdrugresistantmycobacteriumtuberculosisinheyuancityinchina
AT jianhongma prevalenceandmolecularcharacterizationofdrugresistantmycobacteriumtuberculosisinheyuancityinchina
AT zhifangliu prevalenceandmolecularcharacterizationofdrugresistantmycobacteriumtuberculosisinheyuancityinchina
AT xiangxingzeng prevalenceandmolecularcharacterizationofdrugresistantmycobacteriumtuberculosisinheyuancityinchina